Treatment as Prevention¨

Virological suppression and co-morbidities are the main focus of consultations between HIV healthcare providers (HCPs) and their patients, according to results of a study conducted by NAM and presented to the recent 15th European AIDS Conference held in Barcelona. Almost 90% of HCPs said the main focus of appointments with patients taking antiretroviral therapy (ART) […]

HIV clinicians will deliberate on how to put evidence into policy and action. This year marks the 30th year of India’s fight against AIDS, and for the first time, the world has obtained evidence backing antiretroviral therapy (ART) treatment to those testing positive for HIV, regardless of CD4. WHO has accordingly revised its guidelines. The

O mŽdico e pesquisador argentino radicado no Canadá, Julio Montaner – criador da estratŽgia “Tratamento como Prevenção” (“Treatment as key to Prevention”/TasP) – fará a conferência de abertura do 10º Congresso de HIV/Aids e do 3° Congresso de Hepatites Virais “Novos Horizontes, Novas Respostas”, do MinistŽrio da Saúde: “Por que pensar no fim da epidemia

While epidemiologists and public health experts are excited by the potential of new hepatitis C drugs to limit onward transmission of the virus among people who inject drugs, the strategies ignore profound barriers to drug users engaging with healthcare and their broader needs. For ‘treatment as prevention’ to be ethical and acceptable to people who

Another significant change in 2015 is acceptance for how ART reduces the chance of transmitting HIV. With an undetectable viral load, in many cases this risk is close to zero. Although this has been known for many years, there is now much better evidence, including for gay men as well as heterosexual couples. The European

Since the early 1980s, HIV/AIDS has claimed tens of millions of lives. The pandemic has touched every corner of the world, affected young and old, rich and poor and men and women of all backgrounds. It has been one of the worst scourges in human history, Anthony S. Fauci, M.D., a leading HIV/AIDS researcher and

A partir desta quarta-feira (21/10), o portal do Departamento de DST, Aids e Hepatites Virais (DDAHV) do MinistŽrio da Saúde publicará matŽrias semanais em preparação à abertura – em novembro – do 10º Congresso de HIV/Aids e do 3° Congresso de Hepatites Virais “Novos Horizontes, Novas Respostas”. Os dois eventos serão realizados entre os dias

The country has begun a pilot study of Pre-Exposure Prophylaxis (PrEP) and TasP (Treatment as Prevention). The National Agency for the Control of AIDS (NACA) is spearheading the study. Pre-exposure prophylaxis, or PrEP, is a procedure for people who do not have HIV but who are at substantial risk of contracting the virus to prevent

The director of the BC Centre for Excellence in HIV/AIDS finds the Conservative government’s lack of support for a national strategy this election disturbing. Since publishing an open letter to Prime Minister Stephen Harper Sept. 22, asking for them to endorse the United Nations HIV/AIDS strategy, Dr. Julio Montaner has renewed his call. Montaner has